Paskaitos medžiaga (video)


  1. Guobuzaite A, Chokshi S, Balciuniene L, Voinic A, Stikleryte A, Zagminas K, et al. Viral clearance or persistence after acute hepatitis C infection: interim results from a prospective study. Medicina (Kaunas, Lithuania). 2008.
  2. Grebely J, Page K, Sacks-Davis R, van der Loeff MS, Rice TM, Bruneau J, et al. The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection. Hepatology. 2014.
  3. Maasoumy B, Wedemeyer H. Natural history of acute and chronic hepatitis C. Best Practice & Research Clinical Gastroenterology. 2012.
  4. Liakina V, Valantinas J. Anti-HCV prevalence in the general population of Lithuania. Medical Science Monitor : International Medical Journal of Experimental and Clinical Research. 2012.
  5. Liakina V, Speiciene D, Irnius A, Valantinas J. Changes in hepatitis C virus infection routes and genotype distribution in a Lithuanian cohort with chronic hepatitis C. Med Sci Monit. 2009.
  6. Kupčinskas L, Kiudelis G, Jonaitis L, Adamonis K et al. Klinikinė hepatologija (vadovėlis). 2014.
  7. Smith BD, Beckett GA, Yartel A and al.  Previous Exposure to HCV Among Persons Born During 1945–1965: Prevalence and Predictors, United States, 1999–2008. American Journal of Public Health. 2014. 
  8. Colvin HM, Mitchell AE. Hepatitis and liver cancer: A national strategy for prevention and control of hepatitis B and C. 2010.
  9. McQuillan GM, Kruszon-Moran D. Viral hepatitis. NCHS. 2010.
  10. van der Meer AJ et al. Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis. JAMA. 2012.
  11. van der Meer AJ, Hansen BE, Fattovich G, Feld JJ et al. Reliable prediction of clinical outcome in patients with chronic HCV infection and compensated advanced hepatic fibrosis: a validated model using objective and readily available clinical parameters. Gut. 2014.
  12. van der Meer AJ. Achieving sustained virological response: what’s the impact on further hepatitis C virus-related disease? Expert Rev Gastroenterology and Hepatology. 2015.
  13. Younossi ZM, Stapanova M et al. Patient-reported outcomes in chronic hepatitis C patients with cirrhosis treated with sofosbuvir-containing regimens. Hepatology. 2014.
  14. Inglesby TV, Rai R et al. A prospective, community-based evaluation of liver enzymes in individuals with hepatitis C after drug use. Hepatology. 1999.
  15. EASL Recommendations on Treatment of Hepatitis C. 2015.
  16. AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C. 2016.